Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emblem Corp EMMBF

Healthcare Biotechnology Cannabis
"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."


OTCPK:EMMBF - Post by User

Emblem Corp > Whassup with Emblem and these guys?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by deminimison Jan 11, 2018 11:20pm
179 Views
Post# 27339234

RE:Whassup with Emblem and these guys?

RE:Whassup with Emblem and these guys? Emblem has no stake in this company although I suspect they might buy into the $5M bought deal Canntab is doing concurrently with the reverse takeover. 

Emblem’s involvement with this company is that they have licensed Canntab’s Canadian patent on a cannabis sustained release formulation and have entered into a partnership with them to develop other pharmaceutical formulations.

I haven’t done the math on how Telferscot’s shares will be consolidated in the reverse takeover nor do I have any insight on what a fair valuation for Canntab would be but I highly doubt there is any type of arbitrage opportunity here. I am surprised that trading on Telferscot hasn’t been halted. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities